Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Rheumatology/Arthritis Market Research

Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North

Best Price Guarantee Length Publisher Published Date SKU
from $4,500 153 Pages Coherent Market Insights September, 2022 CMI17440788
Best Price Guarantee
Price from $4,500
Length 153 Pages
Publisher Coherent Market Insights
Published Date September, 2022
SKU CMI17440788

Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the body by reducing inflammation and modulating the immune system. This phenomenon makes stem cell therapy a viable treatment option for a variety of medical conditions. Stem cell therapies have been used to treat autoimmune, inflammatory, neurological, orthopedic conditions and traumatic injuries with studies conducted on use for Crohn's disease, Multiple Sclerosis, Lupus, COPD, Parkinson's, ALS, Stroke recovery and more. There are two main types of stem cell transplants: autologous and allogeneic. An autologous stem cell transplant is most often used to treat plasma cell disorders, hodgkin's lymphoma, myeloma and non-hodgkin's lymphoma. There are four types of Adipose-derived stem cells therapy hematopoietic stem cells (HSCs), skin stem cells (SSCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs). There are several types of stem cells that can be used for different purposes. Some of them are mentioned below as flows:

  • Embryonic stem cells. Embryonic stem cells come from human embryos that are three to five days old.
  • Non-embryonic (adult) stem cells.
  • Induced pluripotent stem cells (iPSCs)
  • Cord blood stem cells and amniotic fluid stem cells.
Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life. Mesenchymal stem cells do this by influencing tissue repair via paracrine effects (cell signaling in order to change the behavior of existing cells) or direct cell-to-cell contact.

Market Dynamics

Increasing expansion of facilities by market players for stem cell therapies is expected to propel growth of the stem cell therapy market over the forecast period. For instance, in January 2018, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies and the shared services segment offers technical resources related to stem cell therapies.

Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2018, Procella Therapeutics and Smartwise, a medtech company entered into a collaboration with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca utilized Procella Therapeutics’ stem cell technology for the development of stem cell therapies in cardiovascular diseases. Moreover, in April, 2019, CelluGen Biotech and FamiCord Group, Biotechnology company collaborated to develop new stem cell-based drugs and advanced medical therapies (ATMP).

Key features of the study:
  • This report provides an in-depth analysis of the global stem cell therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global stem cell therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global stem cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market
Detailed Segmentation:
  • Global Stem Cell Therapy Market, By Cell Source:
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • Others
  • Global Stem Cell Therapy Market, By Application:
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune disorders
  • Others
  • Global Stem Cell Therapy Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Magellan
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Medipost Co., Ltd
  • Osiris Therapeutics, Inc.
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Anterogen Co. Ltd.
  • Pharmicell Co., Inc.
  • Stemedica Cell Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Cell Source  Market Snapshot, By Application  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Epidemiology o Market Trends o Product Launch o Regulatory Scenario o Reimbursement Scenario o PEST Analysis o PORTER’s Analysis 4. Global Stem Cell Therapy Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Government Initiatives o COVID-19 Impact on the market 5. Global Stem Cell Therapy Market, By Cell Source, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Adult Stem Cells  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Induced Pluripotent Stem Cells  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Embryonic Stem Cells  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 6. Global Stem Cell Therapy Market, By Application, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Musculoskeletal Disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Wounds and Injuries  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Cancer  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Autoimmune disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. Global Stem Cell Therapy Market, By Region, 2017 – 2030, (US$ Million) o Introduction  Market Share Analysis, By Region, 2022 and 2030 (%)  Y-o-Y Growth Analysis, For Regions, 2017–2030  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis  Magellan o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Market Strategies  Medipost Co., Ltd o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  Osiris Therapeutics, Inc. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  Kolon TissueGene, Inc. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  JCR Pharmaceuticals Co., Ltd. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  Anterogen Co. Ltd. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  Pharmicell Co., Inc. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies  Stemedica Cell Technologies, Inc. o Company Overview o Application Portfolio o Financial Overview o Key Highlights o Market Strategies o Analyst Views 9. Section o References o Research Methodology o About Us and Sales Contact *Browse 27 market data tables and 29 figures on "Global Stem Cell Therapy Market” - forecast to 2030

$4,500
$7,000
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings